EnvisionPath, Unit 1-8-01, Aurora Sovo, Jalan Persiaran Jalil 1, Kuala Lumpur (2026)

16/09/2026

𝗕𝗲𝘆𝗼𝗻𝗱 𝗕𝗼𝗱𝘆 𝗖𝗼𝗺𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻: 𝗦𝗲𝗲 𝗠𝗼𝗿𝗲. 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝗠𝗼𝗿𝗲. 𝗔𝗰𝘁 𝗘𝗮𝗿𝗹𝗶𝗲𝗿.

Health assessment should go beyond weight and BMI.

Introducing ANOVATOR A5 — an advanced, AI-enabled health assessment platform designed to provide a more complete picture of the body in just minutes.

Powered by multi-frequency BIA, 3D vision and AI algorithms, ANOVATOR A5 delivers comprehensive and actionable health insights for individuals across different age groups.

With a single assessment, ANOVATOR A5 evaluates:

✓ Body Composition — understand your body beyond just weight
✓ Cardiovascular Health — gain early insights into cardiovascular risk
✓ Posture Analysis — assess alignment and body shape
✓ Balance Assessment — measure stability and physical control
✓ Functional Fitness — evaluate physical performance and movement
✓ All-Age Assessment — suitable for children, adults and seniors

Clear, visual reports make results easier to understand and help track progress over time — turning measurements into meaningful health actions.

From hospitals and medical centres to wellness clinics, fitness centres, corporate wellness programmes, schools and sports organisations, ANOVATOR A5 supports a wide range of health and wellness applications.

ANOVATOR A5 — Beyond Body Composition.
Precision insights for a healthier tomorrow.

Interested in bringing ANOVATOR A5 to your hospital, clinic, wellness centre, gym or organisation?

Contact EnvisionPath for enquiries, product demonstrations and partnership opportunities:

📞 +60 12-381 1240
✉️ [email protected]
🌐 envision-path.com
📍 Unit 1-8-01, Aurora Sovo, Jalan Persiaran Jalil 1, 57000 Bukit Jalil, Kuala Lumpur, Malaysia

13/09/2026

𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 — 𝗙𝗿𝗼𝗺 𝗦𝗹𝗶𝗱𝗲 𝗣𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗔𝗜-𝗔𝘀𝘀𝗶𝘀𝘁𝗲𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀

EnvisionPath is pleased to introduce the KFBIO Digital Pathology Solutions Portfolio, an integrated ecosystem designed to help hospitals, pathology laboratories and research institutions digitalise the entire pathology workflow — from slide preparation and scanning to image management, telepathology and AI-assisted diagnosis.

The KFBIO platform brings together a broad range of technologies within one connected digital pathology environment, including:

🔬 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗦𝗹𝗶𝗱𝗲 𝗦𝗰𝗮𝗻𝗻𝗲𝗿𝘀
The KF-PRO, KF-FL and KF-PRX scanner families support different laboratory workloads, from compact benchtop systems to high-throughput platforms, including bright-field and fluorescence whole-slide imaging.

⚙️ 𝗙𝘂𝗹𝗹-𝗣𝗿𝗼𝗰𝗲𝘀𝘀 𝗧𝗿𝗮𝗰𝗸𝗶𝗻𝗴 & 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗖𝗼𝗻𝘁𝗿𝗼𝗹
Solutions covering specimen imaging, rotary microtomes, slide printers, recognition systems, stainers and coverslippers help laboratories improve standardisation, traceability and workflow automation.

🧫 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗟𝗶𝗾𝘂𝗶𝗱-𝗕𝗮𝘀𝗲𝗱 𝗖𝘆𝘁𝗼𝗹𝗼𝗴𝘆
KFBIO provides cytology sample preparation, staining reagents and automated production equipment designed to support consistent cell preparation and staining quality.

🖥️ 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘆𝘀𝘁𝗲𝗺
The KFBIO PIMS architecture helps connect scanners, pathology workstations, digital slide data centres and hospital information systems, supporting a more integrated pathology department.

☁️ 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗦𝗹𝗶𝗱𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘆𝘀𝘁𝗲𝗺
Centralised digital slide storage, retrieval, access control and system integration help laboratories manage increasing volumes of whole-slide images while enabling collaboration across sites.

🧠 𝗔𝗜-𝗔𝘀𝘀𝗶𝘀𝘁𝗲𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀
The portfolio also includes AI-assisted applications for areas such as cervical cytology, thyroid cytology and gastric histopathology, supporting image analysis, lesion localisation and diagnostic workflow optimisation.

Rather than adopting digital pathology as a standalone scanner, laboratories can build a connected, scalable and AI-ready pathology ecosystem covering the entire journey from glass slide to digital image, data management and intelligent analysis.

For those interested in KFBIO technologies in Singapore and Brunei, please contact EnvisionPath directly — the sole distributor for KFBIO Digital Pathology Solutions:

🌐 https://envision-path.com/
✉️ [email protected]
📱 +65 8207 0710

For customers in other markets, please contact your local KFBIO distributor to learn more about available products, demonstrations and technical support.

11/09/2026

𝗕𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗕𝗿𝗶𝗴𝗵𝘁-𝗙𝗶𝗲𝗹𝗱 𝗮𝗻𝗱 𝗙𝗹𝘂𝗼𝗿𝗲𝘀𝗰𝗲𝗻𝗰𝗲 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗶𝗻 𝗢𝗻𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺

EnvisionPath is pleased to introduce the KFBIO KF-FL-005 Digital Pathology Slide Scanner, a compact digital pathology solution designed for laboratories requiring both bright-field and fluorescence whole-slide imaging.

The KF-FL-005 digitises tissue slides into high-resolution images for viewing, archiving, sharing and downstream analysis. Its support for bright-field and fluorescence scanning, together with automated slide handling and multiple fluorescence channels, makes it particularly suitable for clinical, research and telepathology applications.

Key capabilities include:

🔬 Bright-field & fluorescence digital slide scanning in a single platform
🌈 Support for up to 8 fluorescence channels
📸 High-resolution imaging down to 0.25 μm/pixel at 20× and 0.125 μm/pixel at 40×
⚙️ Magnetic linear motor control for precise and stable scanning
🎯 Positioning accuracy of approximately 50 nm
📦 Automatic feeding for up to 5 slides
🧬 Support for applications including FISH and fluorescence imaging
💻 Digital images suitable for viewing, storage, remote consultation and image analysis

Designed for versatility, the KF-FL-005 can support workflows ranging from clinical diagnosis and telepathology to scientific research, medical education and multidisciplinary consultation. Its compact format makes it especially attractive for laboratories looking to introduce advanced fluorescence digital pathology without requiring a large-footprint system.

For those interested in KFBIO technologies in Singapore and Brunei, please contact EnvisionPath directly — the sole distributor for KFBIO Digital Pathology Solutions:

🌐 https://envision-path.com/
✉️ [email protected]
📱 +65 8207 0710

For customers in other markets, please contact your local KFBIO distributor to find out more about product availability, demonstrations and support.

09/09/2026

𝗕𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗘𝗿𝗮 𝘄𝗶𝘁𝗵 𝗛𝗶𝗴𝗵-𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗪𝗵𝗼𝗹𝗲-𝗦𝗹𝗶𝗱𝗲 𝗜𝗺𝗮𝗴𝗶𝗻𝗴

EnvisionPath is pleased to introduce the KFBIO Digital Pathology Slide Scanner Series, designed to support hospitals, pathology laboratories, research institutions and digital pathology programmes with high-speed, high-precision whole-slide imaging.

The KF-PRO Series offers scanner capacities ranging from 5 to 400 slides, supporting different laboratory workloads from routine diagnostics and education to high-throughput digital pathology and AI-assisted analysis. The platform is designed for applications including telepathology, frozen-section consultation, digital archiving, research and AI image analysis.

𝗞𝗲𝘆 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

🔬 High-resolution whole-slide imaging at 20× and 40×
⚡ Fast scanning, with selected models capable of scanning a 15 mm × 15 mm area at 20× in approximately 25 seconds
🧠 AI-ready digital images for downstream image analysis and assisted diagnosis
🧫 Support for H&E, IHC, TCT, ISH/FISH and other slide types
📦 Multiple capacities from 5, 20, 40, 120 to 400 slides
🖥️ Digital slide viewing, annotation and remote access
☁️ Support for telepathology and multi-site workflows
📁 Integrated digital slide storage and management
🔗 Support for integration with HIS/LIS workflows

The system also supports Z-stack scanning, high-precision positioning, multiple image formats and optional fluorescence capabilities, providing laboratories with the flexibility to build a digital pathology solution that matches their clinical, research and operational requirements.

For laboratories requiring fluorescence applications, the KF-FL Series supports both bright-field and fluorescence scanning, with configurations of up to 8 fluorescence channels, making it suitable for applications such as FISH, immunofluorescence and advanced research imaging.

With KFBIO scanners reportedly installed across more than 2,000 hospitals and laboratories and having scanned more than 50 million slides, the platform provides a scalable foundation for laboratories moving towards a more connected, digital and AI-enabled pathology workflow.

For those interested in KFBIO technologies in Singapore and Brunei, please contact EnvisionPath directly — the sole distributor for KFBIO Digital Pathology Solutions:

🌐 https://envision-path.com/
✉️ [email protected]
📱 +65 8207 0710

For customers in other markets, please contact your local KFBIO distributor to find out more about product availability, demonstrations and support.

08/09/2026

𝗦𝗺𝗮𝗿𝘁𝗲𝗿 𝗦𝗹𝗶𝗱𝗲 𝗣𝗿𝗶𝗻𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗠𝗼𝗱𝗲𝗿𝗻 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆

EnvisionPath is pleased to introduce the KFBIO KF-UV-150S, a high-speed UV laser slide printer designed to improve efficiency, traceability and workflow integration in histology and pathology laboratories.

With zero-consumable laser marking, printing speeds of up to 20 slides/minute, high-resolution ≥2500 dpi marking, barcode scanner support and compatibility with LIS/HIS/PIS systems, the KF-UV-150S delivers clear, durable slide identification while helping laboratories simplify daily operations. Its compact footprint and intuitive touchscreen interface make it easy to integrate into existing workflows.

For laboratories looking to modernise pathology workflows, the KF-UV-150S offers a practical combination of speed, reliability and automation.

For those interested in KFBIO technologies in Singapore and Brunei, please contact EnvisionPath directly, the sole distributor for KFBIO Digital Pathology Solutions:

🌐 https://envision-path.com/
✉️ [email protected]
📱 +65 8207 0710

For customers in other markets, please contact your local KFBIO distributor to find out more about product availability and support.

28/08/2026

🤝 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝘀 𝗠𝗮𝗹𝗮𝘆𝘀𝗶𝗮–𝗖𝗵𝗶𝗻𝗮 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗭𝗞𝗬𝗛 (中科伊和), 𝗚𝘂𝗮𝗻𝗴𝘅𝗶

We are pleased to announce that EnvisionPath has signed a Memorandum of Understanding (MOU) with ZKYH (中科伊和), Guangxi, China, marking an important step in expanding our role as a Malaysia–China technology and innovation partner.

The collaboration was facilitated with the support of Dr Afnizanfaizal Abdullah from MRANTI and the Ministry of Science, Technology and Innovation (MOSTI), whose efforts continue to strengthen international technology partnerships and create pathways for Malaysian innovations to scale regionally.

ZKYH brings expertise across Artificial Intelligence (AI), medical manufacturing and reproductive health, creating strong synergies with EnvisionPath’s focus on digital pathology, digital health and AI-enabled healthcare solutions.

Importantly, this collaboration goes beyond a conventional distribution arrangement. The MOU establishes a broader platform for cooperation covering:

• Distribution and market development
• Joint grant applications
• Research and development
• Technology transfer
• Product localisation and commercialisation

Through this partnership, both organisations aim to combine complementary strengths in technology, clinical applications, manufacturing and market access to accelerate the development and deployment of innovative healthcare solutions across Malaysia, China and the wider region.

For EnvisionPath, this represents another important step toward our ambition of becoming a regional technology platform connecting AI, digital pathology, digital health and medical innovation.

We believe the future of healthcare innovation will increasingly be built through cross-border collaboration, shared R&D and technology co-development — not simply through buying and selling products.

Our sincere appreciation to MRANTI and MOSTI for facilitating this strategic connection and supporting Malaysian companies in building meaningful global technology partnerships.

From distribution to co-development. From technology transfer to commercialisation. From Malaysia and China to the region.

28/08/2026

🔬 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵 𝗔𝘄𝗮𝗿𝗱𝗲𝗱 𝗕𝗶𝗼𝗡𝗲𝘅𝘂𝘀 𝗦𝘁𝗮𝘁𝘂𝘀 — 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗔𝗜 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 & 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵

We are proud to announce that EnvisionPath has been awarded BioNexus Status by the Ministry of Science, Technology and Innovation (MOSTI), recognising our commitment to advancing digital pathology, artificial intelligence and digital health innovation in Malaysia.

The recognition was received by our Group CEO, Dr Tan Yuen Fen, from YB Chang Lih Kang, Minister of Science, Technology and Innovation.

BioNexus Status represents an important milestone for EnvisionPath. Beyond recognition, it places us within Malaysia’s growing bioinnovation ecosystem and strengthens our ability to accelerate technology development, commercialisation, strategic partnerships and regional expansion.

Our ambition is clear: to build EnvisionPath into a leading AI-powered digital pathology and digital health platform from Malaysia for the world.

We envision a future where pathology is no longer constrained by geography — where digitalisation and AI enable:

🔬 High-resolution digital pathology and whole-slide imaging
🤖 AI-assisted image analysis and clinical decision support
🌏 Remote pathology consultation and regional expert collaboration
⚡ Faster, more standardised diagnostic workflows
🏥 Integration of pathology, genomics and clinical data into connected digital health solutions
📊 Data-driven tools that improve diagnostic efficiency, accessibility and patient care

As healthcare systems face increasing diagnostic workloads and shortages of specialist expertise, we believe digital pathology and AI will become fundamental infrastructure for the next generation of healthcare.

This BioNexus recognition strengthens our commitment to building that future — developing technology in Malaysia, validating it clinically, scaling it across Southeast Asia, and ultimately taking Malaysian digital health innovation to the global stage.

Our sincere appreciation to MOSTI, YB Chang Lih Kang and Malaysia Bioeconomy Development Corporation for supporting the growth of Malaysia’s biotechnology and health technology ecosystem.

From glass slides to digital intelligence. From Malaysia to the world.

23/07/2026

🚀 𝗖𝘆𝘁𝗼𝘃𝗶𝘀𝗶𝗼𝗻 𝗶𝘀 𝗻𝗼𝘄 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵

We are pleased to announce the rebranding of 𝗖𝘆𝘁𝗼𝘃𝗶𝘀𝗶𝗼𝗻 to 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵, marking an important milestone in our journey to advance the future of healthcare technology.

This rebranding reflects a strategic evolution that has been thoughtfully envisioned and developed over time, alongside our expanded portfolio beyond digital pathology into a broader ecosystem of 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵, 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀, 𝗪𝗵𝗼𝗹𝗲-𝗦𝗹𝗶𝗱𝗲 𝗜𝗺𝗮𝗴𝗶𝗻𝗴, 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗗𝗶𝗴𝗶𝘁𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻, 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀.

The name 𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵 represents our commitment to helping healthcare providers, laboratories, hospitals, and partners envision a smarter, more connected, and more efficient path forward in diagnostics and patient care.

While our name has changed, our mission remains the same: to deliver innovative, reliable, and scalable technologies that support better clinical decisions and improve healthcare outcomes.

We look forward to this next chapter and to growing together with our partners locally, regionally, and globally.

𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻𝗣𝗮𝘁𝗵 — 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆. 𝗘𝗻𝗮𝗯𝗹𝗶𝗻𝗴 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵.

01/03/2026

𝗜𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗣𝗮𝗿𝘁𝗻𝗲𝗿: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗡𝗲𝘅𝘁-𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗔𝗜-𝗔𝘀𝘀𝗶𝘀𝘁𝗲𝗱 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿

Digital pathology is entering a new era — one defined by artificial intelligence, large-scale image analytics, and seamless global collaboration. Achieving this vision requires strong partnerships between industry, academia, and healthcare institutions.

Digital Pathology is actively inviting academic institutions, hospitals, AI researchers, and industry partners to collaborate with us in developing the next generation of AI-assisted digital pathology solutions that are scalable, clinically validated, and affordable for widespread adoption.

As one of the leading digital pathology providers in Southeast Asia, Digital Pathology has established strategic collaborations with globally respected partners, including KFBio, Singapore General Hospital, A*STAR Bioinformatics Institute, Universiti Sains Malaysia (USM), International Medical University (IMU), and other leading institutions across the region.

Our innovation efforts are nationally recognized. Digital Pathology has been supported by MOSTI as a pioneer in Digital Pathology and Health AI with its Bionexus status, and our EnvisionPath™ platform has been granted MySTI status, reflecting its role in advancing Malaysia’s biomedical and AI ecosystem.

We welcome partnerships in:
• AI model development and validation
• Clinical research and multi-center studies
• Digital pathology infrastructure deployment
• Translational and computational pathology research
• Joint grants, technology transfer, and commercialization

Together, we can accelerate the development of accessible, high-quality digital pathology solutions that empower clinicians, researchers, and healthcare systems across Asia and beyond.

If your organization is interested in collaboration, we would be pleased to connect and explore partnership opportunities.

03/02/2026

🌏 Digital Pathology 𝗟𝗲𝗮𝗱𝘀 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗦𝗼𝘂𝘁𝗵𝗲𝗮𝘀𝘁 𝗔𝘀𝗶𝗮 𝘄𝗶𝘁𝗵 𝗙𝗶𝗿𝘀𝘁 𝗞𝗙𝗕𝗶𝗼 𝗞𝗙-𝗣𝗥𝗫 𝗜𝗻𝘀𝘁𝗮𝗹𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹

We are proud to announce that Digital Pathology has successfully installed the first KFBio KF-PRX Series Next-Generation Digital Pathology Slide Scanner in Southeast Asia, at Singapore General Hospital.

🔬 𝗪𝗵𝘆 𝘁𝗵𝗲 𝗞𝗙-𝗣𝗥𝗫 𝗦𝗲𝗿𝗶𝗲𝘀 𝗺𝗮𝘁𝘁𝗲𝗿𝘀

🧪 𝗙𝗿𝗼𝗺 𝟮𝟬 𝘁𝗼 𝟭,𝟮𝟬𝟬 𝘀𝗹𝗶𝗱𝗲𝘀
Built for both routine diagnostics and large-scale operations, the KF-PRX supports 24/7 continuous scanning, combining a fast engine with smart software for efficient workflows, storage, and diagnostics.

🎨 𝗧𝗿𝘂𝗲-𝘁𝗼-𝗟𝗶𝗳𝗲 𝗖𝗼𝗹𝗼𝗿
Advanced color processing with ICC calibration ensures accurate, consistent color and contrast—critical for confident interpretation and reproducibility.

🔍 𝗨𝗻𝗺𝗮𝘁𝗰𝗵𝗲𝗱 𝗖𝗹𝗮𝗿𝗶𝘁𝘆
Optimized optics deliver high-resolution images with exceptional sharpness, preserving fine structures and cellular details essential for diagnosis, research, and AI development.

This milestone demonstrates how high-throughput, next-generation whole slide imaging can transform pathology services—delivering faster turnaround times today while laying the groundwork for AI-enabled diagnostics tomorrow.

Thank you to KFBio and our partners for the trust and collaboration. Southeast Asia’s digital pathology journey just took a big leap forward.

EnvisionPath

16/09/2026

13/09/2026

11/09/2026

09/09/2026

08/09/2026

28/08/2026

28/08/2026

23/07/2026

01/03/2026

03/02/2026

Address

Website

Alerts

Shortcuts

Share

Category

Listing takedown request